Skip to content
Screener

AtriCure ATRC Operating Cash Flow

Operating Cash Flow at other companies

Abbott logo
AbbottABT
$2.49B+21.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.62B+122%
Boston Scientific logo
Boston ScientificBSX
$348M-35.7%
Medtronic logo
MedtronicMDT
$2.57B+1.8%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
-$18.71M-46.1%
Artivion logo
ArtivionAORT
-$1.27M-108%

Other financials

Income statement

See full
Revenue$153.6M+12.8%
Gross profit$118.6M+16.9%
Operating income$9.7M+256%
Net income$9.0M+245%
EPS (diluted)$0.18+238%

Balance sheet

See full
Cash & equivalents$167.8M+42.4%
Total debt$75.5M-3.8%
Total equity$516.4M+11.2%
Total assets$676.6M+11.1%

Cash flow

See full
CapEx$3.8M+41.5%
Free cash flow$18.4M-2.8%

Valuation

See full
Market cap$2.01B+10.7%
Enterprise value$1.92B+7.9%
P/E770.8×
P/S3.5×-0.1×

Profitability

See full
Gross margin76.3%+1.6pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.3%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.1×0.0×
Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: AtriCure’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 1:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001323885-26-000035
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Accounts payable9,017(45)
Accrued liabilities(10,060)(5,832)
Other noncurrent assets and liabilities(1,995)(1,001)
Net cash provided by operating activities18,19610,591
Cash flows from investing activities:
Purchases of property and equipment(7,618)(4,843)
Acquisitions, including in-process research and development(5,000)
Proceeds from capital grant500

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is AtriCure's operating cash flow?
AtriCure (ATRC) reported operating cash flow of $22.19M in Q2 2026.
How has AtriCure's operating cash flow changed year-over-year?
AtriCure's operating cash flow increased by 2.7% year-over-year, from $21.62M to $22.19M.
What is the long-term trend for AtriCure's operating cash flow?
Over 3 years (2021 to 2025), AtriCure's operating cash flow has grown at a 59.7% compound annual growth rate (CAGR), from -$14.08M to $57.33M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about AtriCure's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude